[email protected]
Jeff Allen is President and CEO of Friends of Cancer Research (Friends). Friends is an advocacy organization based in Washington, DC that drives collaboration among partners from every healthcare sector to power advances in science, policy, and regulation that speed life-saving treatments to patients.
Jeff manages a leading non-profit cancer research policy and advocacy organization that focuses on innovative research partnerships and healthcare policy particularly related to the Food and Drug Administration (FDA). His responsibilities include creating and implementing research and policy initiatives, organizational governance, coordinating staff for scientific and regulatory programs, fundraising, communications, policy activities, speaking at public symposia, and engaging with congressional leaders, federal officials, and scientific experts. Jeff has helped develop and lead collaborative initiatives aimed to advance and harmonize biomarker development, validate clinical trial endpoints, optimize use of real-world evidence, and establish innovative policies including the Breakthrough Therapy Designation.
Jeff previously worked as an Endocrinology & Immunology Research Fellow at the National Institutes of Health. This involved primary research focused on intracellular signal transduction related to growth regulation and apoptosis. He is also the co-author of over 50 peer-viewed publications in leading medical journals and policy publications and has been called to testify before Congress and contribute expertise to the legislative process on multiple occasions.
Related Speakers View all
Shekinah Elmore
Oncologist; Dedicated to Pursuing Equity & Empathy i...
|
|
Dr. Zoltan Lohinai
Pulmonary Oncologist & Researcher at the National Ko...
|
|
David Williams
Professor of Public Health at Harvard University
|
|
Alice Berger, Ph.D.
Cancer Geneticist & Lung Cancer Researcher
|
|
Haiying Cheng, MD, PhD
Physician-Scientist at Albert Einstein College; Reci...
|
|
Debi Brooks
Co-Founder & Executive Vice Chairman Michael J. Fox ...
|
|
Alex Salter
M.D.- Ph.D. candidate at Fred Hutchinson Cancer Rese...
|
|
Dr. James Allison
2018 Nobel Prize in Medicine Recipient, Chair of Imm...
|
|
H. Gilbert Welch
Professor of Medicine and Public Policy, Dartmouth C...
|
|
Amy Abernethy
President, Product Development and Chief Medical Off...
|
|
David Scadden
Co-Director of the Harvard Stem Cell Institute
|
|
Dr. Francis Collins
Head, Molecular Genetics Section, National Human Gen...
|
|
Deeptee Jain
Minimally Invasive Spine Surgeon at the Center for B...
|
|
Cara Altimus
Managing Director at the Milken Institute SPARC & BD...
|
|
Karen E. Knudsen
CEO of the American Cancer Society
|
|
Linda Goler Blount
President & CEO of Black Women's Health Imperative
|
|
Rebekah Gee
CEO of LSU Healthcare Services; Clinical Associate P...
|
|
Mary-Ann Etiebet
Lead of Merck for Mothers; Assistant Vice President ...
|
|
Kelvin Baggett
Executive Vice President & Chief Impact Officer at M...
|
|
Marcella Nunez-Smith
Chair of the COVID-19 Health Equity Task Force; Asso...
|